Cytora Therapeutics、Made Scientific以及Zeo ScientifiX Inc. 共同宣布，已就Cytora Therapeutics研发的同种异体干细胞疗法在美国境内的生产与商业化达成战略合作伙伴关系。该合作旨在整合三方在技术开发、生产制造及市场拓展方面的优势资源，加速推进这一创新疗法的临床应用进程。
Cytora Therapeutics、Made Scientific以及Zeo ScientifiX Inc. 共同宣布，已就Cytora Therapeutics研发的同种异体干细胞疗法在美国境内的生产与商业化达成战略合作伙伴关系。该合作旨在整合三方在技术开发、生产制造及市场拓展方面的优势资源，加速推进这一创新疗法的临床应用进程。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.